Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hippo and Hyperplasia.

× No keyword cloud information.

14 in total

Review 1. Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways.

Authors: Giulia Santinon; Arianna Pocaterra; Sirio Dupont
Journal: Trends Cell Biol Date: 2015-12-30 Impact factor: 20.808

2. Hippo-YAP and mTOR pathways collaborate to regulate organ size.

Authors: Alfred Csibi; John Blenis
Journal: Nat Cell Biol Date: 2012-12 Impact factor: 28.824

3. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.

Authors: Deanna N Edwards; Verra M Ngwa; Shan Wang; Eileen Shiuan; Dana M Brantley-Sieders; Laura C Kim; Albert B Reynolds; Jin Chen
Journal: Sci Signal Date: 2017-12-05 Impact factor: 8.192

Review 4. Molecular regulation of vascular smooth muscle cell differentiation in development and disease.

Authors: Gary K Owens; Meena S Kumar; Brian R Wamhoff
Journal: Physiol Rev Date: 2004-07 Impact factor: 37.312

Review 5. mTOR Signaling in Growth, Metabolism, and Disease.

Authors: Robert A Saxton; David M Sabatini
Journal: Cell Date: 2017-03-09 Impact factor: 41.582

Review 6. Recent insights into the cellular biology of atherosclerosis.

Authors: Ira Tabas; Guillermo García-Cardeña; Gary K Owens
Journal: J Cell Biol Date: 2015-04-13 Impact factor: 10.539

7. Opposing Actions of AKT (Protein Kinase B) Isoforms in Vascular Smooth Muscle Injury and Therapeutic Response.

Authors: Yu Jin; Yi Xie; Allison C Ostriker; Xinbo Zhang; Renjing Liu; Monica Y Lee; Kristen L Leslie; Waiho Tang; Jing Du; Seung Hee Lee; Yingdi Wang; William C Sessa; John Hwa; Jun Yu; Kathleen A Martin
Journal: Arterioscler Thromb Vasc Biol Date: 2017-10-12 Impact factor: 8.311

8. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis.

Authors: Sripal Bangalore; Bora Toklu; Nicholas Amoroso; Mario Fusaro; Sunil Kumar; Edward L Hannan; David P Faxon; Frederick Feit
Journal: BMJ Date: 2013-11-08

Review 9. Targeting Glutamine Metabolism for Cancer Treatment.

Authors: Yeon-Kyung Choi; Keun-Gyu Park
Journal: Biomol Ther (Seoul) Date: 2018-01-01 Impact factor: 4.634

10. TEAD1 (TEA Domain Transcription Factor 1) Promotes Smooth Muscle Cell Proliferation Through Upregulating SLC1A5 (Solute Carrier Family 1 Member 5)-Mediated Glutamine Uptake.

Authors: Islam Osman; Xiangqin He; Jinhua Liu; Kunzhe Dong; Tong Wen; Fanzhi Zhang; Luyi Yu; Guoqing Hu; Hongbo Xin; Wei Zhang; Jiliang Zhou
Journal: Circ Res Date: 2019-04-26 Impact factor: 17.367

1 in total

Review 1. Targeting smooth muscle cell phenotypic switching in vascular disease.

Authors: Raja Chakraborty; Payel Chatterjee; Jui M Dave; Allison C Ostriker; Daniel M Greif; Eva M Rzucidlo; Kathleen A Martin
Journal: JVS Vasc Sci Date: 2021-05-15

1 in total